US Drug Recall Register
Class I · High risk Terminated Initiated Feb 3, 2022 (5 years ago)

HYDROmorphone HCl PF 10 mg/50 mL

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

What was recalled

HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.

Recalling firm
STAQ Pharma, Inc.
Origin
CO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0633-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Hydromorphone recalls

See all
Class III · Low risk Ongoing

Hydromorphone HCL PF

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

STAQ Pharma, Inc. NDC 73177-0104-05 D-0023-2026
Class III · Low risk Terminated

HYDROmorphone Hydrochloride 50mg/50mL

Reason Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..

OurPharma LLC NDC 73013-1040-01 D-0385-2025